Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06866119 · ClinicalTrials.gov registry record
Effects of Estrogen on Heart Health in Women With Primary Ovarian Insufficiency
A clinical trial, sponsored by Massachusetts General Hospital.
- Not yet
- Registry status
- 45
- Enrollment target
NCT06866119: Clinical Trial study, sponsored by Massachusetts General Hospital.
NCT06866119 is a clinical trial that has not yet begun recruiting, run by Massachusetts General Hospital. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06866119 has not yet begun recruiting, sponsored by Massachusetts General Hospital.
- NOT YET RECRUITING
- Registry status
- 45 participants
- Enrollment target
Study Summary
The goal of this observational study is to study the effects of treating women with Primary Ovarian Insufficiency (POI) with estrogen replacement therapy to bolster the evidence backing cardiometabolic preventive care in women with POI. The main question it aims to answer is: Does 6 months of estrogen replacement therapy for women with POI improved markers of heart health? Women newly diagnosed with POI (within 6 months) who are planning to start estrogen replacement therapy from their clinical provider will undergo assessment of markers of heart health before and after 6 months of treatment. These markers will also be compared to those obtained from healthy women without POI.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2026-03-01 |
| Est. Completion | 2026-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06866119
The ClinicalTrials.gov registry entry for NCT06866119 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT06866119 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06866119 about?
NCT06866119 is a clinical study titled "Effects of Estrogen on Heart Health in Women With Primary Ovarian Insufficiency". The goal of this observational study is to study the effects of treating women with Primary Ovarian Insufficiency (POI) with estrogen replacement therapy to bolster the evidence backing cardiometabolic preventive care in women with POI. The main question it aims to answer is: Does 6 months of estro...
What is the current status of trial NCT06866119?
This trial is currently not yet recruiting. The enrollment target is 45 participants. The study started on 2026-03-01. Estimated completion is 2026-06.
Who is sponsoring clinical trial NCT06866119?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.